Instituto de Investigação e Inovação em Saúde, Universidade do Porto
Rua Alfredo Allen, 208 4200-135 Porto, Portugal
Phone: +351 226 074 900
Email: info@i3s.up.pt
Our group works at the interface of immunology, cancer and glycobiology, using a combination of in vitro, ex vivo and in vivo approaches.
The group’s research has been published in a number of high-impact publications over the years.
The group’s research explores several topics related to the impact of glycans on inflammation, autoimmunity and cancer.
OUR GROUP MAIN LINES OF RESEARCH:
The exploitation of the cellular and molecular mechanisms by which glycans contribute to amplify immune response in chronic inflammation and autoimmunity.
OUR GROUP MAIN LINES OF RESEARCH:
The investigation of how cancer-specific glycosignatures regulate the immunological networks in cancer.
Pedro Cabral and Ana Campar have recently been awarded by NEDAI (Núcleo de Estudos de Doenças Auto-Imunes) at its XI National Congress, which also marked the XXX Annual Meeting of Autoimmunity in Portugal. Each was distinguished by their pioneering work in lupus nephritis and idiopathic inflammatory myopathies, respectively.
Pinho’s Lab has recently published a landmark study on colitis-associated colorectal cancer (CAC) in the Journal of Crohn’s and Colitis! Therein, we demonstrate that a progressive increase in N-glycan branching at the T cell surface not only accompanies CAC development but also debilitates T cell function during carcinogenesis.
Pinho´s Lab was honoured to receive the Best Paper Award 2025 at the Annual Meeting of the Portuguese Society for Immunology (SPI – Sociedade Portuguesa de Imunologia), which took place in Lisbon last April.